These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 3579206)
1. Improvement of disability and akinesia of patients with Parkinson's disease by intravenous iron substitution. Birkmayer JG; Birkmayer W Ann Clin Lab Sci; 1987; 17(1):32-5. PubMed ID: 3579206 [TBL] [Abstract][Full Text] [Related]
2. [Comparative evaluation of the therapeutic effect of oxyferriscorbone in peptic ulcer]. Spivak AM; Reĭngardt VK; Galetskaia TM; Liashko NA; Litinskaia EV Vrach Delo; 1985 Aug; (8):56-9. PubMed ID: 4072113 [No Abstract] [Full Text] [Related]
3. [Use of sodium oxyferriscorbone, lidocaine and therapeutic endoscopy in peptic ulcer]. Starodub EM; Zhukovskiĭ MN; Shust ZI; Faryniuk SG; Markiv IM Vrach Delo; 1984 Sep; (9):11-3. PubMed ID: 6506628 [No Abstract] [Full Text] [Related]
5. [Local activation of reparative processes in chronic gastroduodenal ulcer]. Buianov VM; Fokin NS; Perminova GI Klin Khir (1962); 1981 Aug; (8):1-4. PubMed ID: 7278010 [No Abstract] [Full Text] [Related]
6. Milestones in the development of modern Parkinson therapy. Birkmayer W J Neural Transm Suppl; 1987; 25():1-3. PubMed ID: 3123596 [No Abstract] [Full Text] [Related]
7. Iron, a new aid in the treatment of Parkinson patients. Birkmayer W; Birkmayer JG J Neural Transm; 1986; 67(3-4):287-92. PubMed ID: 3806082 [TBL] [Abstract][Full Text] [Related]
9. [Local treatment of stomach and duodenal ulcers]. Tolman DV; Levin VF; Shevchenko NI Vrach Delo; 1984 Sep; (9):13-7. PubMed ID: 6506632 [No Abstract] [Full Text] [Related]
10. Oxyferriscorbone elevates the total iron content of blood but not brain. Dexter DT; Jenner P; Marsden CD Mov Disord; 1989; 4(2):176-82. PubMed ID: 2733708 [TBL] [Abstract][Full Text] [Related]
14. Patient benefits of l-dopa and a decarboxylase inhibitor in the treatment of Parkinson's disease in elderly patients. Admani AK; Verma S; Cordingley GJ; Harris RI Pharmatherapeutica; 1985; 4(2):132-40. PubMed ID: 4059292 [TBL] [Abstract][Full Text] [Related]
15. [A new levodopa benserazide preparation for Parkinson's disease with motor fluctuations refractory to standard L-dopa]. Fernández Pardal MM; Gatto E; Micheli F; Casas Parera I; Diaz S Medicina (B Aires); 1991; 51(6):561-7. PubMed ID: 7476112 [TBL] [Abstract][Full Text] [Related]
16. [Drug therapy of Parkinson's syndrome. Clinical long-term study using L-dopa and the drug conbination L-dopa-decarboxylase inhibitor]. Christiani K; Möller WD Munch Med Wochenschr; 1973 Apr; 115(16):711-3. PubMed ID: 4197759 [No Abstract] [Full Text] [Related]
17. [Indices of gastric secretion and pH measurement in patients with duodenal peptic ulcer]. Zaiachuk VM; Parashchak AP; Neĭko EM; Denisiuk VG Vrach Delo; 1988 Oct; (10):52-5. PubMed ID: 3218199 [No Abstract] [Full Text] [Related]
18. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946 [TBL] [Abstract][Full Text] [Related]
19. [Effectiveness of slow release L-DOPA/benserazide in treatment of end-of-dose akinesia in Parkinson disease]. Eichhorn TE; Schrag A; Trenkwalder C; Selzer R; Kohnen R; Oertel WH; Poewe W Nervenarzt; 1995 Dec; 66(12):933-41. PubMed ID: 8584079 [TBL] [Abstract][Full Text] [Related]
20. [Improvements in motor and non-motor symptoms in parkinson patients under ropinirole therapy]. Buchwald B; Angersbach D; Jost WH Fortschr Neurol Psychiatr; 2007 Apr; 75(4):236-41. PubMed ID: 17427044 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]